TOP 5 MOST VIEWED ARTICLES
RECENT COMMENTS
Article type: Masterpiece
Keywords: Bob Pinedo, medical oncology, .
This article has 0 comments
Bob Pinedo: Bringing two worlds together
At the tender age of 29, Dr Pinedo found himself in charge of a group of cancer patients who were being left to die, and he set out to find a way to treat them. What followed was a remarkable story of one man and his lab, whose pioneering work brought new hope to a generation of patients and helped set the standards for translational research.
» Interview by Anna Wagstaff
To read complete article please click on the pdf icon
COMMENTS (0)
When submitted, your comment will be moderated. Messages which may be considered defamatory, which incite hatred or contain foul or abusive language, or are gratuitously offensive, will not be published. Please ensure that your comments are concise and relevant to the topic in question. Off-topic comments and comments without a username will not be published.
ESO reserves the absolute right not to publish comments.
ESO reserves the absolute right not to publish comments.
CancerWorld invites you to visit:
European School of Oncology -
ESO Established in 1982, a non-profit organisation exclusively dedicated to increasing the knowledge of health professionals in cancer care.
ESO Established in 1982, a non-profit organisation exclusively dedicated to increasing the knowledge of health professionals in cancer care.
Euro-Arab School of Oncology - is a joint initiative between the Egyptian Ministry of Health and Population and ESO. EASO intends to enhance and support education in the oncology field in all the Arab countries.
CancerWorld is a pioneering initiative of the European School of Oncology financially supported through Sharing Progress in Cancer Care, a collaborative programme between ESO and Amgen, Celgene, Eisai, Eli Lilly, Genomic Health, GlaxoSmithKline, Merck Serono, Novartis, Roche and Sanofi Aventis.






